Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 53749 results
Veristat acquires UK-based CRO, Spero Oncology
Veristat, a full service Clinical Research Organization (CRO), is expanding its clinical research offerings into Europe through the acquisition of UK-based CRO, Spero Oncology.
Drug Research > Drug Delivery > News
Protalex receives positive interim review in European phase 1b study of PRTX-100 to treat immune thrombocytopenia
Protalex announced that following a planned interim data review by its independent Safety Monitoring Committee (SMC), the Company is continuing enrollment and increasing the dose for subjects in its European Phase 1b study of PRTX-100 in adults with persistent/chronic Immune Thrombocytopenia (ITP) (PRTX-100-203 Study).
Contract Research & Services > Clinical Trials > News
EMD Serono expands biopharmaceutical R&D facility in Billerica, Massachusetts
EMD Serono, the biopharmaceutical business of Merck KGaA, in North America, announced a $12m investment for the expansion of its R&D facility in Billerica, Massachusetts.
Production & Manufacturing > Manufacturing > News
Seres achieves target enrollment of SER-109 phase 2 study to prevent recurrent clostridium difficile infection
Seres Therapeutics announced that the target enrollment of 87 patients has been achieved for its ongoing SER-109 Phase 2 clinical study.
Contract Research & Services > Clinical Trials > News
Perrigo receives final FDA approval for generic version of Valeant's BenzaClin Pump Topical Gel
Perrigo has received final US Food and Drug Administration (FDA) approval for the generic version of Valeant Pharmaceutical International's BenzaClin Pump Topical Gel.
Production & Manufacturing > OTC > News
Health Canada approves Vanc Pharmaceuticals' Cortivera-H product for minor skin irritations
Health Canada has approved Vanc Pharmaceuticals' Cortivera-H, a premium topical product for minor skin irritations.
Production & Manufacturing > OTC > News
Graybug Vision secures $44.5m funding for clinical development activities
By PBR Staff Writer
Venture-stage pharmaceutical firm Graybug Vision has secured $44.5m in funding for clinical development activities.
Drug Research > Drug Discovery & Development > News
Researchers find new treatment for lethal resistant prostate cancers
Researchers from the Institute of Cancer Research (ICR), London, have said that a new type of drug could benefit men with aggressive prostate cancer that has stopped responding to treatment.
Contract Research & Services > Contract Research > News
FDA approves new formulation of Eisai’s Fycompa to treat seizure disorders
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved Eisai’s Fycompa (perampanel) oral suspension as adjunctive therapy to treat partial-onset seizures (POS) with or without secondarily generalized seizures, and primary generalized tonic-clonic (PGTC) seizures.
Regulatory Affairs > News
Business Review is looking for a new online reporter
We are looking for an online staff writer to research and write articles on our website Pharmaceutical Business Review.
Ablynx announces milestone in drug discovery collaboration with Novartis
Ablynx has received an undisclosed milestone payment from its collaboration with Novartis.
Drug Research > Drug Discovery & Development > News
Concert Pharmaceuticals unveils positive data from multiple dose phase 1 trial of CTP-656
Concert Pharmaceuticals announced positive topline data from a Phase 1 multiple ascending dose clinical trial of CTP-656.
Contract Research & Services > Clinical Trials > News
Heritage Pharmaceuticals issues product safety warning counterfeit drug product BiCNU
Heritage Pharmaceuticals announced that it recently became aware of the existence of a counterfeit drug product labeled as BiCNU (Carmustine for Injection) 100mg that has been sold and distributed outside of the US.
Drug Research > Drug Delivery > News
Gilead Sciences receives positive CHMP opinion for Odefsey to treat HIV
By PBR Staff Writer
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Gilead Sciences' fixed-dose HIV combination pill Odefsey featuring emtricitabine 200 mg, rilpivirine 25 mg, and tenofovir alafenamide (TAF) 25 mg.
Production & Manufacturing > Process & Production > News
European CHMP adopts positive opinion for Afinitor to treat select GI and lung neuroendocrine tumors
By PBR Staff Writer
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for Novartis' Afinitor (everolimus) tablets to treat select gastrointestinal (GI) and lung neuroendocrine tumors (NETs).
Production & Manufacturing > Process & Production > News

PBR Supplier Recommendations

Bruker Optics - Fourier Transform Infrared, Near Infrared and Raman Spectrometers
Bruker Optics is the leading manufacturer and worldwide supplier of fourier transform Infrared (FTIR), near infrared and raman spectrometers for a number of industries and applications, such as pharmaceutical and life sciences.... Automation > Laboratory Instrumentation > Suppliers
LABORATORIOS INIBSA - Pharmaceutical Contract Manufacturing Company
LABORATORIOS INIBSA is a pharmaceutical contract manufacturing company. We have more than 60 years' experience and belong to the INIBSA GROUP. INIBISA supplies products and services to Biotools, Inibsa Dental and Inibsa Hospital, as well as other pharmaceutical companies through our contract manufacturing division. From our facilities in Lliçà de Vall, 20km from Barcelona LABORATORIOS INIBSA currently supplies more than 50 countries worldwide.... Production & Manufacturing > Manufacturing > Suppliers
SHL Group - Pen Injectors, Autoinjectors and Inhaler Systems
SHL is a privately-owned developer, designer and manufacturer of advanced drug delivery devices.... Regulatory Affairs > Suppliers
MEGGLE – Experts in Excipients: The Whole World of Lactose
MEGGLE Excipients & Technology is a global leader in the manufacture of lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio of lactose excipients, co-processed technologies and excipient contract manufacturing.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Russell Finex - Fine Mesh Separation Technology
Russell Finex are worldwide leaders in fine mesh separation technology, designing and manufacturing vibratory sieves, separators, self-cleaning in-line filters and ultrasonic systems.... Production & Manufacturing > Process & Production > Suppliers
See more

PBR White Paper Recommendations

1.5 Specific dsDNA Quantification UV/VIS-based cDrop™ Method vs Picogreen® Fluorescent Assay By Trinean
Precise quantification and normalization of isolated genomic DNA is critical for advanced molecular testing in life science research and molecular diagnostics. UV-Vis based quantification has long been the method of choice, mainly because of its convenience. However, determining the DNA concentration based on the absorbance at 260nm suffers from interference of components such as RNA, proteins and phenols. Alternative methods, such as the PicoGreen® based Quant-iT™ assay, based on fluorescence enhancement upon binding with dsDNA have been developed to address this issue.... Drug Research > Drug Discovery & Development > White Papers 1.3 Micro-volume Protein Quantification using the DropSense96 Droplet Plate Reader By Trinean
The measurement of protein concentration in aqueous samples is an important assay in biochemistry research and protein production facilities. Spectrophotometric protein quantification assays are commonly used methods to rapidly determine the concentration of a protein. They utilize the direct UV absorbance of the protein at 280nm in combination with its extinction coefficient or an indirect dye-based methods like BCA, Lowry and Bradford assays.... Drug Research > Drug Discovery & Development > White Papers 1.2 DropSense96 and its DropPlates, a Versatile Tool for Nucleic Acid and Protein Droplet Quantification By Trinean
As the demand for molecular tests increases, automated systems for biomolecule isolation and sample analysis are becoming popular. These facilitate integration of the complete molecular test in a full automatic set-up with liquid robots and bar-coded sample tracking resulting in a significant higher throughput while minimizing tedious manual repetitive tasks. The Trinean technology is a unique combination of the DropSense96 droplet plate reader, the 96well DropPlate microfuidic consumables and the DropQuant analytical software enabling direct quantification of small biomolecule samples in these high throughput, automated workflow.... Drug Research > Drug Discovery & Development > White Papers 1.14 Droplet UV/VIS Quantification of Native Proteins in Biopharmaceutical Processing By Trinean
Biopharmaceuticals are mainly produced by microbial fermentation or in animal cell cultures. As a consequence, a cascade of procedures including purification and characterization are required throughout the processing chain to obtain the protein at the desired level of purity and potency. Within these processes, quantification of the protein of interest is mandatory at critical steps to maintain confidence in the processing results and fidelity in the end product.... Drug Research > Drug Discovery & Development > White Papers 1.20 Quantification of His-tagged IgG antibodies after IMAC Ni-column purification By Trinean
Trinean introduces a new cDrop™ application suited for the quantification (OD280) of IgG antibodies and derivatives like Fab fragments during purification by IMAC Ni-columns using imidazole-containing buffers.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 53749 results